{
    "name": "evolocumab",
    "comment": "Rx",
    "other_names": [
        "Repatha"
    ],
    "classes": [
        "Lipid-Lowering Agents",
        "PCSK9 Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/repatha-evolocumab-1000002",
    "pregnancy": {
        "common": [
            "No available data on use in pregnant women",
            "Monoclonal antibodies in humans indicate that they are unlikely to cross the placenta in the first trimester; however, they are likely to cross the placenta in increasing amounts in the second and third trimesters",
            "There is a pregnancy safety study for REPATHA; if administered during pregnancy, healthcare providers should report exposure by contacting Amgen at 1-800-77-AMGEN (1-800-772-6436) or https://wwwext.amgen.com/products/global-patient-safety/adverse-event-reporting"
        ],
        "specific": [
            {
                "type": "Animal studies",
                "description": [
                    "No effects on pregnancy or neonatal/infant development when monkeys were subcutaneously administered evolocumab from organogenesis through parturition at dose exposures up to 12 times the exposure at the maximum recommended human dosage",
                    "In a similar study with another drug in the PCSK9 inhibitor antibody class, humoral immune suppression was observed in infant monkeys exposed to that drug in utero at all doses"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Unknown if distributed in human breast milk",
            "The development and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for the drug and any potential adverse effects on the breastfed infant",
            "Human IgG is present in human milk, but published data suggest that breastmilk IgG antibodies do not enter the neonatal and infant circulation in substantial amounts"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "History of serious hypersensitivity to evolocumab or any excipients"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Hypersensitivity",
                    "description": [
                        "Hypersensitivity reactions (eg, angioedema) reported, including some that led to discontinuation of therapy",
                        "If signs or symptoms of serious allergic reactions occur, discontinue treatment, treat accordingly and monitor until signs and symptoms resolve",
                        "Needle cover of glass single-dose prefilled syringe and single-dose prefilled autoinjector contain dry natural rubber (latex derivative) which may cause an allergic reaction in individuals sensitive to latex"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Nasopharyngitis",
            "percent": "4-10.5"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "2.1-9.3"
        },
        {
            "name": "Influenza",
            "percent": "1.2-7.5"
        },
        {
            "name": "Back pain",
            "percent": "2.3-6.2"
        },
        {
            "name": "Injection site reactions",
            "percent": "3.2-5.7"
        },
        {
            "name": "Allergic reaction",
            "percent": "5.1"
        },
        {
            "name": "Cough",
            "percent": "1.2-4.5"
        },
        {
            "name": "Urinary tract infection",
            "percent": "1.3-4.5"
        },
        {
            "name": "Sinusitis",
            "percent": "4.2"
        },
        {
            "name": "Headache",
            "percent": "4"
        },
        {
            "name": "Myalgia",
            "percent": "4"
        },
        {
            "name": "Dizziness",
            "percent": "3.7"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "3.3"
        },
        {
            "name": "Hypertension",
            "percent": "3.2"
        },
        {
            "name": "Diarrhea",
            "percent": "3"
        },
        {
            "name": "Gastroenteritis",
            "percent": "3"
        },
        {
            "name": "Arthralgia",
            "percent": "1.8"
        },
        {
            "name": "Nausea",
            "percent": "1.8"
        },
        {
            "name": "Fatigue",
            "percent": "1.6"
        },
        {
            "name": "Muscle spasms",
            "percent": "1.3"
        },
        {
            "name": "Contusion",
            "percent": "1"
        },
        {
            "name": "Oropharyngeal pain",
            "percent": "7"
        },
        {
            "name": "Allergic reactions",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        }
    ]
}